Our findings of increased gene expression of IL-22 and its related family of cytokines in tumor tissue, as well as increased protein expression of IL-22, IL-22R, and the downstream modulator pSTAT-3, all reinforce the importance of the IL-22 pathway in TSCCs. This evidence concerns the gene IL22RA1 and neoplasm.